WHO ‘Strongly Advises Against’ Use of These Two Covid-19 Antibody Therapies
16/09/2022 1 minute read
Spread the love
In the same guideline update, WHO makes a conditional recommendation for the use of the antiviral drug remdesivir in patients with severe COVID19, and a conditional recommendation against its use in patients with critical disease.
